Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Rate of benign histology after resection of suspected renal cell carcinoma: multicenter comparison between Korea and the United States

    In the United States, the rate of benign histology among resected renal tumors suspected to be malignant is increasing. We evaluated the rates in the Republic of Korea and assessed the racial effect using rece...

    Chang Wook Jeong, Jang Hee Han, Seok Soo Byun, Cheryn Song, Sung-Hoo Hong in BMC Cancer (2024)

  2. Article

    Open Access

    Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

    Novel perioperative strategies are needed to reduce recurrence rates in patients undergoing nephrectomy for high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC). We conducted a prospective, phase ...

    Nirmish Singla, Thomas R. Nirschl, Aleksandar Z. Obradovic in Scientific Reports (2024)

  3. No Access

    Article

    Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility

    To describe the perioperative safety, functional and immediate post-operative oncological outcomes of minimally invasive RPLND (miRPLND) for testis cancer.

    Christian D. Fankhauser, Luca Afferi, Sean P. Stroup in World Journal of Urology (2022)

  4. No Access

    Article

    Testicular ultrasound underestimates the size of small testicular masses: a radiologic–pathologic correlation study

    Increasing use and resolution of testicular ultrasound imaging has resulted in a greater diagnosis of non-palpable small testicular masses and subsequent over-treatment with orchiectomy. Our aim was to determi...

    Zeyad R. Schwen, James L. Liu, Andrew T. Gabrielson in World Journal of Urology (2021)

  5. No Access

    Article

    Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers

    Surveillance for small renal masses is a growing choice of management amongst physicians and patients. These decisions, however, can be difficult as patient factors and tumor factors may blur the line between ...

    Sunil H. Patel, Nirmish Singla, Phillip M. Pierorazio in World Journal of Urology (2021)

  6. No Access

    Article

    A prospective comparative study of routine versus deferred pelvic drain placement after radical prostatectomy: impact on complications and opioid use

    To evaluate the association of post-RP drain placement with post-operative complications and opioid use at a high-volume institution.

    Mitchell M. Huang, Hiten D. Patel, Zhuo T. Su in World Journal of Urology (2021)

  7. No Access

    Article

    Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience

    The objectives were to evaluate the safety and oncologic efficacy of primary robotic retroperitoneal lymph node (R-RPLND) dissection for testicular germ cell tumors. A retrospective analysis was performed on a...

    Andrew D. Supron, Joseph G. Cheaib, Michael J. Biles in Journal of Robotic Surgery (2021)

  8. No Access

    Article

    Surgical ergonomics for urologists: a practical guide

    Poor ergonomics in the operating room can have detrimental effects on a surgeon’s physical, psychological and economic well-being. This problem is of particular importance to urologists who are trained in near...

    Andrew T. Gabrielson, Marisa M. Clifton, Christian P. Pavlovich in Nature Reviews Urology (2021)

  9. No Access

    Chapter

    Oncologic Monitoring After Radical Nephroureterectomy

    Tumor recurrence after radical nephroureterectomy (RNU) for upper tract urothelial cell carcinoma (UTUCC) can occur in the bladder, the contralateral upper urinary tract, or systemically. Therefore, oncologic ...

    Natasha Gupta, Jean H. Hoffman-Censits, Phillip M. Pierorazio in Bladder Cancer (2021)

  10. Article

    Advanced renal cell carcinoma and COVID-19 — a personal perspective

    The management pathways of advanced renal cell carcinoma (RCC) have considerably evolved in the past 5 years, presenting a particular challenge during the coronavirus disease 2019 (COVID-19) pandemic. In this ...

    Yasser Ged, Mark C. Markowski, Phillip M. Pierorazio in Nature Reviews Urology (2020)

  11. Article

    Open Access

    Extracellular vesicle isolation from human renal cancer tissue

    Renal cell carcinoma is a lethal disease that is often discovered incidentally. New non-invasive biomarkers are needed to aid diagnosis and treatment. Extracellular vesicles (EVs), membranous vesicles secreted...

    Richard C. Zieren, Liang Dong, Phillip M. Pierorazio, Kenneth J. Pienta in Medical Oncology (2020)

  12. No Access

    Chapter

    Active Surveillance of Renal Tumors

    Asymptomatic solid small renal masses are an increasingly common clinical entity. While most small renal masses are malignant, many have limited metastatic potential as evidenced by a significant proportion of...

    Hiten D. Patel, Phillip M. Pierorazio in Diagnosis and Surgical Management of Renal Tumors (2019)

  13. No Access

    Article

    Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases

    Determining the metastatic viability of suspicious retroperitoneal nodes in testicular cancer with conventional imaging is challenging. The aim of this report is to review recent evidence in the utilization of...

    Gregory A. Joice, Steven P. Rowe, Michael A. Gorin in Current Urology Reports (2018)

  14. No Access

    Article

    Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes

    While retroperitoneal lymph node dissection (RPLND) is traditionally reserved for nonseminomatous germ cell tumors, recent efforts to reduce long-term toxicities of radiation and chemotherapy have turned atten...

    Hiten D. Patel, Gregory A. Joice, Zeyad R. Schwen in World Journal of Urology (2018)

  15. No Access

    Article

    Frontiers in robot-assisted retroperitoneal oncological surgery

  16. Robotic assistance has been rapidly adopted by urologists for a wide range of surgical procedures involving the retroperitoneal space

  17. ...

    Wesley W. Ludwig, Michael A. Gorin, Phillip M. Pierorazio in Nature Reviews Urology (2017)

  18. Article

    Open Access

    Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

    99mTc-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has recently been explored for the characterization of indeterminate renal masses. As judged b...

    Steven P. Rowe, Michael A. Gorin, Lilja B. Solnes, Mark W. Ball in EJNMMI Research (2017)

  19. No Access

    Article

    Undertreatment of small renal masses by overuse of biopsy

    Recent evidence from series of small renal mass biopsy samples and methodologically robust meta-analyses provides improved guidance on cost–benefit trade-offs for diagnosis and management of this disease. Rena...

    Hiten D. Patel, Phillip M. Pierorazio in Nature Reviews Urology (2016)

  20. No Access

    Article

    Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes

    Patients diagnosed with stage I non-seminomatous germ cell tumor (NSGCT) face the task of selecting a management strategy. Whereas these options all offer excellent survival, unfortunately, each has drawbacks....

    Heather J. Chalfin, Wesley Ludwig, Phillip M. Pierorazio in Current Urology Reports (2016)

  21. No Access

    Article

    Active Surveillance for Small Renal Masses: A Review of the Aims and Preliminary Results of the DISSRM Registry

    Active surveillance is an increasingly accepted treatment modality for select patients with small renal masses. The DISSRM (delayed intervention and surveillance for small renal masses) registry is a multi-ins...

    Matthew R. Danzig, Peter Chang, Andrew A. Wagner in Current Urology Reports (2015)

  22. No Access

    Chapter

    Beyond BCG: Taxanes

    Many patients undergoing intravesical therapy for superficial bladder cancer will fail initial treatment; therefore additional bladder-sparing options are needed for these patients. The taxanes are potentially...

    James M. McKiernan, Phillip M. Pierorazio in Bladder Cancer (2010)

previous disabled Page of 2